Assistant Professor @ Stanford ChemE synthetic biology, biomolecular engineering https://xitter.cf/t.co/KAajKt7YdT

Stanford, CA
Joined June 2019
Xiaojing Gao retweeted
Regulatable in vivo gene expression via adaptamers sciencedirect.com/science/ar…
1
11
1
69
4,957
Xiaojing Gao retweeted
As with biological design, AI can also accelerate biological discovery. In new work led by @_David_Li and @garykbrixi with @mfgrp, we show how genome language models enable systematic discovery of genetic elements, revealing a new class of reverse-transcriptase mechanisms.
4
61
7
344
32,711
Efficient generation of epitope-targeted antibodies with Germinal - @BrianHie @SynBioGaoLab nature.com/articles/s41587-0…
2
30
157
13,863
Nifty work on plasmid chromatinization from @stergachislab ! "plasmids are indeed capable of recapitulating nuclear genome-encoded chromatin architectures, ... However, plasmids consistently adopt a heterogeneous and incomplete chromatin architecture relative to nuclear-encoded chromatin fibers, and surrounding sequence context plays an integral role in modulating whether a plasmid-encoded regulatory element will recapitulate nuclear genome-encoded chromatin architectures."
Online Now: Chromatin architectures underlying plasmid-based assays for regulatory variant effects dlvr.it/TSkLhj
19
34
10,544
Xiaojing Gao retweeted
I have long written and spoken about the many ways US immigration policy harms international students and scholars. This has been true for as long as I can remember, including when I first came to the US on a single-entry student visa more than 20 years ago under a process formerly known as muslim registry program. But the current administration has gone much further, through arbitrary policy changes, travel bans, and broad visa processing pauses that leave folks unable to work, travel, or train. These policies affect a minority of scientists, and in the current state of the world they can be easy to overlook. But we should not let that happen. I wrote about the quiet loss of Iranian scientific talent in US labs for @TheScientistLLC: the-scientist.com/the-quiet-…
326
107
33
484
281,024
qPCR allowed us to measure transcripts, but just once, destructively, and only in post-mortem tissues. Here, we show we can record transcript level history in vivo and recover this information with a blood test to make a "noninvasive qPCR". nature.com/articles/s41467-0…
3
37
2
150
14,774
Xiaojing Gao retweeted
Replying to @Doudna_lab
This is not real.
1
2
19
10,588
Xiaojing Gao retweeted
Excited to report the first de novo enzyme catalyzing two of the most energetically demanding reactions in biology—phosphomonoester and phosphodiester hydrolysis—with catalytic efficiencies comparable to natural enzymes! 🚀 desB was designed zero-shot with dEVA. No structure prediction, no pre-defined motif, no reaction-intermediates. 🧵 @StanfordBiosci @bioe_stanford @SLAClab @EPFL @hes_so @simonduerr
2
62
4
280
25,318
Xiaojing Gao retweeted
Could the folding of synthetic gene circuits in 3D shape how genes are expressed? Today @ScienceMagazine we report on the role of gene syntax in shaping feedback between transcriptional activity and genome folding for advanced circuit design🧵 (1/n)
23
187
14
689
73,245
So you want to engineer your hiPSCs, but targeting DNA payloads requires multiple slow, inefficient steps for each construct. What if we could accomplish multi-site integration seamlessly? Come hear about STRAIGHT-IN Dual now out at Nature Biomedical Engineering! 🧵 Link at end!
3
41
6
153
16,265
Xiaojing Gao retweeted
So excited that our work on Programmable Macromolecule Delivery via Engineered Trogocytosis is out in @NatureCellBio! Link: rdcu.be/fa90i @stanleyqilab @Stanford_ChEMH @bioe_stanford @StanfordBioX A 🧵on our story:
3
8
1
33
5,339
Engineering the next frontier of mammalian systems. Accepting abstracts through April 15 - submit yours now: bit.ly/4jQmrFj #mSBW2026 #SyntheticBiology #MammalianSystems #CallForAbstracts
2
1
8
689
Xiaojing Gao retweeted
Important paper from Jason Chin's and Julian Sale's labs realizing key operations needed for building synthetic human genomes. My repeated reaction reading this paper was "um, I didn't know you could just do that." science.org/doi/abs/10.1126/…
3
29
3
131
17,770
Xiaojing Gao retweeted
Thrilled to share our new paper in Cell! We show that phase separation can buffer growth-mediated dilution in synthetic circuits by stabilizing gene expression under dynamic conditions, bringing spatial control into the genetic design toolbox Proud of our amazing team & collaborators! cell.com/cell/fulltext/S0092…
1
6
18
1,523
Xiaojing Gao retweeted
I am delighted to share this work, led by Miguel Alcantar and done in collaboration with Amgen, on the OrthoRep-driven evolution of computationally designed minibinders. Here, we focus not only on getting to high affinity, but also on mapping sequence-affinity landscapes of diverse evolutionary outcomes. One way we arrive at diverse evolutionary outcomes is through "neutral drift" where we take one binder and diverge it into many by selecting for the maintenance of (but not improvement of) binding. This is very easy to do with OrthoRep because rapid mutation of the binder occurs autonomously. The result is a rich sequence-affinity dataset spanning both a range of sequences and affinities. We are now scaling these approaches, including to antibodies and a broad array of targets, to get the right distribution and volume of data for training generative models for binder design. biorxiv.org/content/10.1101/…
2
21
2
116
13,714
Xiaojing Gao retweeted
It’s back! 🎉 The Stanford–UCSC Advanced Techniques in Neuroimaging Workshop returns April 13–17, 2026 🧠💡 Learn from experts, hands on experience. Free and housing included! Spots are limited — apply now and spread the word! #Neuroimaging #Zuolab med.stanford.edu/beckman/ATN…
1
35
1
169
14,628
Our RAEFISH spatial transcriptomics technology is now published in Cell @CellCellPress! RAEFISH enables sequencing-free whole genome spatial transcriptomics at single molecule resolution. This work represents the first time that transcripts from more than 23,000 genes were directly probed and imaged in situ with any technology, and the first time numerous different gRNAs were directly probed and distinguished by imaging in a high-content CRISPR screen. The challenge: Recent breakthroughs in spatial transcriptomic technologies, from us and others, have greatly improved our ability to profile cell types, states, cellular interactions, and the underlying gene programs within the native tissue contexts. However, these technologies have limitations. Methods based on 2D-array-capture/tagging and ex situ sequencing offer genome-scale coverage, but lack the resolution needed to accurately study fine spatial organization. In contrast, image-based methods that rely on highly multiplexed fluorescence in situ hybridization or in situ sequencing provide single-molecule resolution and resolve fine spatial organization, but require pre-selecting a limited set of target genes (typically hundreds to a few thousand genes), which limits discovery and sometimes leads to only validations of prior knowledge due to the pre-selected targets being well studied in the context. The solution: RAEFISH, our lab's new flagship image-based spatial transcriptomics technology, simultaneously enables single-molecule spatial resolution and whole-genome level coverage of long and short, endogenous and engineered RNA species in cell cultures and intact tissues. The results: 🔥 We performed RAEFISH targeting 23,312 human genes in cell cultures, and demonstrated hypothesis-free discovery of cell cycle associated genes and subcellular localization patterns of transcripts, including nearly the entire protein coding transcriptome and additional long noncoding RNAs. 🔥 We performed RAEFISH targeting 21,955 mouse genes in mouse liver, placenta, and lymph node tissues. Our analyses on immediately neighboring cells uncovered intriguing cell-cell interactions and previously unknown gene expression programs underlying the interactions, such as those between cholangiocytes and immune cells. 🔥 Finally, we further developed RAEFISH to directly read out guide RNAs (gRNAs), demonstrating Perturb-RAEFISH in an image-based high-content CRISPR screen. The capacity of Perturb-RAEFISH to directly read out gRNAs addresses a crucial limitation of previous techniques that read out a barcode/identifier sequence paired with each gRNA species, as the pairing can be shuffled due to RNA recombination intrinsic to lentivirus used in such screens, which limits screen sensitivity and accuracy. In summary, RAEFISH provides the biomedical research community with a generalizable research tool, which will bring more spatial and mechanistic insights across health and disease. This work was co-led by my postdocs Drs. @ChengYubao, Shengyuan Dang, and Yuan Zhang, and was supported by the @NIH, @genome_gov, @sennetresearch, and @psscra. I would like to thank our co-authors, funding agencies, editor, reviewers, and my whole lab @YaleGenetics @YaleCellBio @YaleCancer @YaleMed @Yale. Link to paper: cell.com/cell/fulltext/S0092…
18
119
5
418
49,476
Xiaojing Gao retweeted
Super excited to share what we’ve been working on in collaboration with @SynBioGaoLab over the past few months on de novo antibody design. Check out this great thread by our team lead @santimillef highlighting the technical aspects of the pipeline!
The ability to design antibodies against any protein of interest has major implications for medicine, biotech, and basic science. Today, we introduce Germinal, a pipeline for epitope-targeted de novo antibody design achieving  4–22% success rates with efficient experimental validation.
4
17
108
12,112